Sensei Biotherapeutics (SNSE) Q1 2025 Earnings
SNSE·Reported May 6, 2025·Before market open
Diluted EPS came in at $-5.40 (+15.6% YoY), missed the $-4.20 consensus by $1.20.
Diluted EPS
$-5.40missed by $1.20
Consensus: $-4.20
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Sensei Biotherapeutics's Q1 2025 earnings report.
Sensei Biotherapeutics (SNSE) reported Q1 2025 earnings on May 6, 2025 before market open.
Sensei Biotherapeutics reported diluted EPS of $-5.40 for Q1 2025.
EPS missed the consensus estimate of $-4.20 by $1.20.
Compared to the same quarter a year prior, diluted EPS grew 15.6% from $-6.40.
You can read the 10-Q periodic report (0000950170-25-064525) directly on SEC EDGAR. The filing index links above go to sec.gov.